MIM
SNY icon

Marshall Investment Management’s Sanofi SNY Stock Holding History

Marshall Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Buy
+26
New +$1.16K ﹤0.01% 417

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Marshall Investment Management's SNY Position: Q2 2026 in Review

Marshall Investment Management opened a new position in Sanofi (SNY) in Q2 2026: 26 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings.

714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Marshall Investment Management held 26 shares of Sanofi worth $1.11K as of Q2 2026.
  • Sanofi was a new Marshall Investment Management position in Q2 2026.
  • Sanofi made up ﹤0.01% of Marshall Investment Management's portfolio in Q2 2026, its #417 holding.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Marshall Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.